Monthly
US$200
Billed every month
Sign in to subscribePregabalin Capsules
Matched- Active ingredients (original)
- PREGABALIN
- Dosage form (original)
- CAPSULE
- Route (original)
- ORAL
Read these limits
- US patent expiration does not establish Chinese patent expiration. Dates here come from the US Orange Book; Chinese patent status needs separate checking.
- The Orange Book lists holder-submitted patents and does not cover all related patents.
- “Unmatched” means no English ingredient-name counterpart in the Chinese official-name sources loaded here; it does not mean no Chinese approval or filing. A zero count means a Chinese name is matched but no records were found in the loaded source. Source dates appear below.
- This page contains no sales or market-size data and cannot establish development value.
- Names on unmatched rows are the original FDA Orange Book names, without Chinese translation. The same ingredient may have a different generic name in China.
US-approved products
Application numbers, product numbers and original fields are retained. Marketing status is shown as listed in the source.
Earliest approval2004/12/30
ANDA applications37
RLD applicantUPJOHN US 2 LLC
Currently marketed products: 180 · Counts FDA prescription and OTC marketing categories as listed; discontinued or unknown categories are excluded.
| Application / product number | Brand name (original) | Applicant (original) | Dosage form (original) | Route (original) | Strength (original) | Earliest approval | RLD / RS | Marketing status (original) | Official source |
|---|---|---|---|---|---|---|---|---|---|
| A091025-001 | PREGABALIN | ACTAVIS ELIZABETH LLC | CAPSULE | ORAL | PREGABALIN: 25MG | 2020/07/09 | N / N | DISCONTINUED | openFDA ↗ |
| A091025-002 | PREGABALIN | ACTAVIS ELIZABETH LLC | CAPSULE | ORAL | PREGABALIN: 50MG | 2020/07/09 | N / N | DISCONTINUED | openFDA ↗ |
| A091025-003 | PREGABALIN | ACTAVIS ELIZABETH LLC | CAPSULE | ORAL | PREGABALIN: 75MG | 2020/07/09 | N / N | DISCONTINUED | openFDA ↗ |
| A091025-004 | PREGABALIN | ACTAVIS ELIZABETH LLC | CAPSULE | ORAL | PREGABALIN: 100MG | 2020/07/09 | N / N | DISCONTINUED | openFDA ↗ |
| A091025-005 | PREGABALIN | ACTAVIS ELIZABETH LLC | CAPSULE | ORAL | PREGABALIN: 150MG | 2020/07/09 | N / N | DISCONTINUED | openFDA ↗ |
| A091025-006 | PREGABALIN | ACTAVIS ELIZABETH LLC | CAPSULE | ORAL | PREGABALIN: 200MG | 2020/07/09 | N / N | DISCONTINUED | openFDA ↗ |
| A091025-007 | PREGABALIN | ACTAVIS ELIZABETH LLC | CAPSULE | ORAL | PREGABALIN: 225MG | 2020/07/09 | N / N | DISCONTINUED | openFDA ↗ |
| A091025-008 | PREGABALIN | ACTAVIS ELIZABETH LLC | CAPSULE | ORAL | PREGABALIN: 300MG | 2020/07/09 | N / N | DISCONTINUED | openFDA ↗ |
| A091040-001 | PREGABALIN | LUPIN LTD | CAPSULE | ORAL | PREGABALIN: 25MG | 2022/05/03 | N / N | DISCONTINUED | openFDA ↗ |
| A091040-002 | PREGABALIN | LUPIN LTD | CAPSULE | ORAL | PREGABALIN: 50MG | 2022/05/03 | N / N | DISCONTINUED | openFDA ↗ |
| A091040-003 | PREGABALIN | LUPIN LTD | CAPSULE | ORAL | PREGABALIN: 75MG | 2022/05/03 | N / N | DISCONTINUED | openFDA ↗ |
| A091040-004 | PREGABALIN | LUPIN LTD | CAPSULE | ORAL | PREGABALIN: 100MG | 2022/05/03 | N / N | DISCONTINUED | openFDA ↗ |
| A091040-005 | PREGABALIN | LUPIN LTD | CAPSULE | ORAL | PREGABALIN: 150MG | 2022/05/03 | N / N | DISCONTINUED | openFDA ↗ |
| A091040-006 | PREGABALIN | LUPIN LTD | CAPSULE | ORAL | PREGABALIN: 200MG | 2022/05/03 | N / N | DISCONTINUED | openFDA ↗ |
| A091040-007 | PREGABALIN | LUPIN LTD | CAPSULE | ORAL | PREGABALIN: 225MG | 2022/05/03 | N / N | DISCONTINUED | openFDA ↗ |
| A091040-008 | PREGABALIN | LUPIN LTD | CAPSULE | ORAL | PREGABALIN: 300MG | 2022/05/03 | N / N | DISCONTINUED | openFDA ↗ |
| A091157-001 | PREGABALIN | SUN PHARMACEUTICAL INDUSTRIES LTD | CAPSULE | ORAL | PREGABALIN: 25MG | 2019/11/29 | N / N | DISCONTINUED | openFDA ↗ |
| A091157-002 | PREGABALIN | SUN PHARMACEUTICAL INDUSTRIES LTD | CAPSULE | ORAL | PREGABALIN: 50MG | 2019/11/29 | N / N | DISCONTINUED | openFDA ↗ |
| A091157-003 | PREGABALIN | SUN PHARMACEUTICAL INDUSTRIES LTD | CAPSULE | ORAL | PREGABALIN: 75MG | 2019/11/29 | N / N | DISCONTINUED | openFDA ↗ |
| A091157-004 | PREGABALIN | SUN PHARMACEUTICAL INDUSTRIES LTD | CAPSULE | ORAL | PREGABALIN: 100MG | 2019/11/29 | N / N | DISCONTINUED | openFDA ↗ |
| A091157-005 | PREGABALIN | SUN PHARMACEUTICAL INDUSTRIES LTD | CAPSULE | ORAL | PREGABALIN: 150MG | 2019/11/29 | N / N | DISCONTINUED | openFDA ↗ |
| A091157-006 | PREGABALIN | SUN PHARMACEUTICAL INDUSTRIES LTD | CAPSULE | ORAL | PREGABALIN: 200MG | 2019/11/29 | N / N | DISCONTINUED | openFDA ↗ |
| A091157-007 | PREGABALIN | SUN PHARMACEUTICAL INDUSTRIES LTD | CAPSULE | ORAL | PREGABALIN: 225MG | 2019/11/29 | N / N | DISCONTINUED | openFDA ↗ |
| A091157-008 | PREGABALIN | SUN PHARMACEUTICAL INDUSTRIES LTD | CAPSULE | ORAL | PREGABALIN: 300MG | 2019/11/29 | N / N | DISCONTINUED | openFDA ↗ |
| A091219-001 | PREGABALIN | TEVA PHARMACEUTICALS USA | CAPSULE | ORAL | PREGABALIN: 25MG | 2019/07/19 | N / N | DISCONTINUED | openFDA ↗ |
| A091219-002 | PREGABALIN | TEVA PHARMACEUTICALS USA | CAPSULE | ORAL | PREGABALIN: 50MG | 2019/07/19 | N / N | DISCONTINUED | openFDA ↗ |
| A091222-001 | PREGABALIN | PHARMOBEDIENT CONSULTING LLC | CAPSULE | ORAL | PREGABALIN: 25MG | 2025/02/21 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A091222-002 | PREGABALIN | PHARMOBEDIENT CONSULTING LLC | CAPSULE | ORAL | PREGABALIN: 50MG | 2025/02/21 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A091222-003 | PREGABALIN | PHARMOBEDIENT CONSULTING LLC | CAPSULE | ORAL | PREGABALIN: 75MG | 2025/02/21 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A091222-004 | PREGABALIN | PHARMOBEDIENT CONSULTING LLC | CAPSULE | ORAL | PREGABALIN: 100MG | 2025/02/21 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A091222-005 | PREGABALIN | PHARMOBEDIENT CONSULTING LLC | CAPSULE | ORAL | PREGABALIN: 150MG | 2025/02/21 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A091222-006 | PREGABALIN | PHARMOBEDIENT CONSULTING LLC | CAPSULE | ORAL | PREGABALIN: 200MG | 2025/02/21 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A091222-007 | PREGABALIN | PHARMOBEDIENT CONSULTING LLC | CAPSULE | ORAL | PREGABALIN: 225MG | 2025/02/21 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A091222-008 | PREGABALIN | PHARMOBEDIENT CONSULTING LLC | CAPSULE | ORAL | PREGABALIN: 300MG | 2025/02/21 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A091224-001 | PREGABALIN | TEVA PHARMACEUTICALS USA | CAPSULE | ORAL | PREGABALIN: 75MG | 2019/07/19 | N / N | DISCONTINUED | openFDA ↗ |
| A091224-002 | PREGABALIN | TEVA PHARMACEUTICALS USA | CAPSULE | ORAL | PREGABALIN: 100MG | 2019/07/19 | N / N | DISCONTINUED | openFDA ↗ |
| A091224-003 | PREGABALIN | TEVA PHARMACEUTICALS USA | CAPSULE | ORAL | PREGABALIN: 150MG | 2019/07/19 | N / N | DISCONTINUED | openFDA ↗ |
| A091224-004 | PREGABALIN | TEVA PHARMACEUTICALS USA | CAPSULE | ORAL | PREGABALIN: 200MG | 2019/07/19 | N / N | DISCONTINUED | openFDA ↗ |
| A091224-005 | PREGABALIN | TEVA PHARMACEUTICALS USA | CAPSULE | ORAL | PREGABALIN: 225MG | 2019/07/19 | N / N | DISCONTINUED | openFDA ↗ |
| A091224-006 | PREGABALIN | TEVA PHARMACEUTICALS USA | CAPSULE | ORAL | PREGABALIN: 300MG | 2019/07/19 | N / N | DISCONTINUED | openFDA ↗ |
| A091228-001 | PREGABALIN | PHARMOBEDIENT CONSULTING LLC | CAPSULE | ORAL | PREGABALIN: 25MG | 2019/09/20 | N / N | DISCONTINUED | openFDA ↗ |
| A091228-002 | PREGABALIN | PHARMOBEDIENT CONSULTING LLC | CAPSULE | ORAL | PREGABALIN: 50MG | 2019/09/20 | N / N | DISCONTINUED | openFDA ↗ |
| A091228-003 | PREGABALIN | PHARMOBEDIENT CONSULTING LLC | CAPSULE | ORAL | PREGABALIN: 75MG | 2019/09/20 | N / N | DISCONTINUED | openFDA ↗ |
| A091228-004 | PREGABALIN | PHARMOBEDIENT CONSULTING LLC | CAPSULE | ORAL | PREGABALIN: 100MG | 2019/09/20 | N / N | DISCONTINUED | openFDA ↗ |
| A091228-005 | PREGABALIN | PHARMOBEDIENT CONSULTING LLC | CAPSULE | ORAL | PREGABALIN: 150MG | 2019/09/20 | N / N | DISCONTINUED | openFDA ↗ |
| A091228-006 | PREGABALIN | PHARMOBEDIENT CONSULTING LLC | CAPSULE | ORAL | PREGABALIN: 200MG | 2019/09/20 | N / N | DISCONTINUED | openFDA ↗ |
| A091228-007 | PREGABALIN | PHARMOBEDIENT CONSULTING LLC | CAPSULE | ORAL | PREGABALIN: 225MG | 2019/09/20 | N / N | DISCONTINUED | openFDA ↗ |
| A091228-008 | PREGABALIN | PHARMOBEDIENT CONSULTING LLC | CAPSULE | ORAL | PREGABALIN: 300MG | 2019/09/20 | N / N | DISCONTINUED | openFDA ↗ |
| A203459-001 | PREGABALIN | ALEMBIC PHARMACEUTICALS LTD | CAPSULE | ORAL | PREGABALIN: 25MG | 2019/07/19 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A203459-002 | PREGABALIN | ALEMBIC PHARMACEUTICALS LTD | CAPSULE | ORAL | PREGABALIN: 50MG | 2019/07/19 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A203459-003 | PREGABALIN | ALEMBIC PHARMACEUTICALS LTD | CAPSULE | ORAL | PREGABALIN: 75MG | 2019/07/19 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A203459-004 | PREGABALIN | ALEMBIC PHARMACEUTICALS LTD | CAPSULE | ORAL | PREGABALIN: 100MG | 2019/07/19 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A203459-005 | PREGABALIN | ALEMBIC PHARMACEUTICALS LTD | CAPSULE | ORAL | PREGABALIN: 150MG | 2019/07/19 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A203459-006 | PREGABALIN | ALEMBIC PHARMACEUTICALS LTD | CAPSULE | ORAL | PREGABALIN: 200MG | 2019/07/19 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A203459-007 | PREGABALIN | ALEMBIC PHARMACEUTICALS LTD | CAPSULE | ORAL | PREGABALIN: 225MG | 2019/07/19 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A203459-008 | PREGABALIN | ALEMBIC PHARMACEUTICALS LTD | CAPSULE | ORAL | PREGABALIN: 300MG | 2019/07/19 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A205321-001 | PREGABALIN | AUROBINDO PHARMA LTD | CAPSULE | ORAL | PREGABALIN: 25MG | 2023/03/29 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A205321-002 | PREGABALIN | AUROBINDO PHARMA LTD | CAPSULE | ORAL | PREGABALIN: 50MG | 2023/03/29 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A205321-003 | PREGABALIN | AUROBINDO PHARMA LTD | CAPSULE | ORAL | PREGABALIN: 75MG | 2023/03/29 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A205321-004 | PREGABALIN | AUROBINDO PHARMA LTD | CAPSULE | ORAL | PREGABALIN: 100MG | 2023/03/29 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A205321-005 | PREGABALIN | AUROBINDO PHARMA LTD | CAPSULE | ORAL | PREGABALIN: 150MG | 2023/03/29 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A205321-006 | PREGABALIN | AUROBINDO PHARMA LTD | CAPSULE | ORAL | PREGABALIN: 200MG | 2023/03/29 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A205321-007 | PREGABALIN | AUROBINDO PHARMA LTD | CAPSULE | ORAL | PREGABALIN: 225MG | 2023/03/29 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A205321-008 | PREGABALIN | AUROBINDO PHARMA LTD | CAPSULE | ORAL | PREGABALIN: 300MG | 2023/03/29 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A205924-001 | PREGABALIN | MACLEODS PHARMACEUTICALS LTD | CAPSULE | ORAL | PREGABALIN: 25MG | 2024/11/12 | N / N | DISCONTINUED | openFDA ↗ |
| A205924-002 | PREGABALIN | MACLEODS PHARMACEUTICALS LTD | CAPSULE | ORAL | PREGABALIN: 50MG | 2024/11/12 | N / N | DISCONTINUED | openFDA ↗ |
| A205924-003 | PREGABALIN | MACLEODS PHARMACEUTICALS LTD | CAPSULE | ORAL | PREGABALIN: 75MG | 2024/11/12 | N / N | DISCONTINUED | openFDA ↗ |
| A205924-004 | PREGABALIN | MACLEODS PHARMACEUTICALS LTD | CAPSULE | ORAL | PREGABALIN: 100MG | 2024/11/12 | N / N | DISCONTINUED | openFDA ↗ |
| A205924-005 | PREGABALIN | MACLEODS PHARMACEUTICALS LTD | CAPSULE | ORAL | PREGABALIN: 150MG | 2024/11/12 | N / N | DISCONTINUED | openFDA ↗ |
| A205924-006 | PREGABALIN | MACLEODS PHARMACEUTICALS LTD | CAPSULE | ORAL | PREGABALIN: 200MG | 2024/11/12 | N / N | DISCONTINUED | openFDA ↗ |
| A205924-007 | PREGABALIN | MACLEODS PHARMACEUTICALS LTD | CAPSULE | ORAL | PREGABALIN: 225MG | 2024/11/12 | N / N | DISCONTINUED | openFDA ↗ |
| A205924-008 | PREGABALIN | MACLEODS PHARMACEUTICALS LTD | CAPSULE | ORAL | PREGABALIN: 300MG | 2024/11/12 | N / N | DISCONTINUED | openFDA ↗ |
| A206452-001 | PREGABALIN | CADILA PHARMACEUTICALS LTD | CAPSULE | ORAL | PREGABALIN: 25MG | 2023/07/12 | N / N | DISCONTINUED | openFDA ↗ |
| A206452-002 | PREGABALIN | CADILA PHARMACEUTICALS LTD | CAPSULE | ORAL | PREGABALIN: 50MG | 2023/07/12 | N / N | DISCONTINUED | openFDA ↗ |
| A206452-003 | PREGABALIN | CADILA PHARMACEUTICALS LTD | CAPSULE | ORAL | PREGABALIN: 75MG | 2023/07/12 | N / N | DISCONTINUED | openFDA ↗ |
| A206452-004 | PREGABALIN | CADILA PHARMACEUTICALS LTD | CAPSULE | ORAL | PREGABALIN: 100MG | 2023/07/12 | N / N | DISCONTINUED | openFDA ↗ |
| A206452-005 | PREGABALIN | CADILA PHARMACEUTICALS LTD | CAPSULE | ORAL | PREGABALIN: 150MG | 2023/07/12 | N / N | DISCONTINUED | openFDA ↗ |
| A206452-006 | PREGABALIN | CADILA PHARMACEUTICALS LTD | CAPSULE | ORAL | PREGABALIN: 200MG | 2023/07/12 | N / N | DISCONTINUED | openFDA ↗ |
| A206452-007 | PREGABALIN | CADILA PHARMACEUTICALS LTD | CAPSULE | ORAL | PREGABALIN: 225MG | 2023/07/12 | N / N | DISCONTINUED | openFDA ↗ |
| A206452-008 | PREGABALIN | CADILA PHARMACEUTICALS LTD | CAPSULE | ORAL | PREGABALIN: 300MG | 2023/07/12 | N / N | DISCONTINUED | openFDA ↗ |
| A206752-001 | PREGABALIN | ZYDUS PHARMACEUTICALS USA INC | CAPSULE | ORAL | PREGABALIN: 25MG | 2022/12/09 | N / N | DISCONTINUED | openFDA ↗ |
| A206752-002 | PREGABALIN | ZYDUS PHARMACEUTICALS USA INC | CAPSULE | ORAL | PREGABALIN: 50MG | 2022/12/09 | N / N | DISCONTINUED | openFDA ↗ |
| A206752-003 | PREGABALIN | ZYDUS PHARMACEUTICALS USA INC | CAPSULE | ORAL | PREGABALIN: 75MG | 2022/12/09 | N / N | DISCONTINUED | openFDA ↗ |
| A206752-004 | PREGABALIN | ZYDUS PHARMACEUTICALS USA INC | CAPSULE | ORAL | PREGABALIN: 100MG | 2022/12/09 | N / N | DISCONTINUED | openFDA ↗ |
| A206752-005 | PREGABALIN | ZYDUS PHARMACEUTICALS USA INC | CAPSULE | ORAL | PREGABALIN: 150MG | 2022/12/09 | N / N | DISCONTINUED | openFDA ↗ |
| A206752-006 | PREGABALIN | ZYDUS PHARMACEUTICALS USA INC | CAPSULE | ORAL | PREGABALIN: 200MG | 2022/12/09 | N / N | DISCONTINUED | openFDA ↗ |
| A206752-007 | PREGABALIN | ZYDUS PHARMACEUTICALS USA INC | CAPSULE | ORAL | PREGABALIN: 225MG | 2022/12/09 | N / N | DISCONTINUED | openFDA ↗ |
| A206752-008 | PREGABALIN | ZYDUS PHARMACEUTICALS USA INC | CAPSULE | ORAL | PREGABALIN: 300MG | 2022/12/09 | N / N | DISCONTINUED | openFDA ↗ |
| A206912-001 | PREGABALIN | HETERO LABS LTD UNIT III | CAPSULE | ORAL | PREGABALIN: 25MG | 2019/10/08 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A206912-002 | PREGABALIN | HETERO LABS LTD UNIT III | CAPSULE | ORAL | PREGABALIN: 50MG | 2019/10/08 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A206912-003 | PREGABALIN | HETERO LABS LTD UNIT III | CAPSULE | ORAL | PREGABALIN: 75MG | 2019/10/08 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A206912-004 | PREGABALIN | HETERO LABS LTD UNIT III | CAPSULE | ORAL | PREGABALIN: 100MG | 2019/10/08 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A206912-005 | PREGABALIN | HETERO LABS LTD UNIT III | CAPSULE | ORAL | PREGABALIN: 150MG | 2019/10/08 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A206912-006 | PREGABALIN | HETERO LABS LTD UNIT III | CAPSULE | ORAL | PREGABALIN: 200MG | 2019/10/08 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A206912-007 | PREGABALIN | HETERO LABS LTD UNIT III | CAPSULE | ORAL | PREGABALIN: 225MG | 2019/10/08 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A206912-008 | PREGABALIN | HETERO LABS LTD UNIT III | CAPSULE | ORAL | PREGABALIN: 300MG | 2019/10/08 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A206942-001 | PREGABALIN | TORRENT PHARMACEUTICALS LTD | CAPSULE | ORAL | PREGABALIN: 25MG | 2025/02/21 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A206942-002 | PREGABALIN | TORRENT PHARMACEUTICALS LTD | CAPSULE | ORAL | PREGABALIN: 50MG | 2025/02/21 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A206942-003 | PREGABALIN | TORRENT PHARMACEUTICALS LTD | CAPSULE | ORAL | PREGABALIN: 75MG | 2025/02/21 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A206942-004 | PREGABALIN | TORRENT PHARMACEUTICALS LTD | CAPSULE | ORAL | PREGABALIN: 100MG | 2025/02/21 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A206942-005 | PREGABALIN | TORRENT PHARMACEUTICALS LTD | CAPSULE | ORAL | PREGABALIN: 150MG | 2025/02/21 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A206942-006 | PREGABALIN | TORRENT PHARMACEUTICALS LTD | CAPSULE | ORAL | PREGABALIN: 200MG | 2025/02/21 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A206942-007 | PREGABALIN | TORRENT PHARMACEUTICALS LTD | CAPSULE | ORAL | PREGABALIN: 225MG | 2025/02/21 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A206942-008 | PREGABALIN | TORRENT PHARMACEUTICALS LTD | CAPSULE | ORAL | PREGABALIN: 300MG | 2025/02/21 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A207799-001 | PREGABALIN | ALKEM LABORATORIES LTD | CAPSULE | ORAL | PREGABALIN: 75MG | 2019/07/19 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A207799-002 | PREGABALIN | ALKEM LABORATORIES LTD | CAPSULE | ORAL | PREGABALIN: 100MG | 2019/07/19 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A207799-003 | PREGABALIN | ALKEM LABORATORIES LTD | CAPSULE | ORAL | PREGABALIN: 150MG | 2019/07/19 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A207799-004 | PREGABALIN | ALKEM LABORATORIES LTD | CAPSULE | ORAL | PREGABALIN: 200MG | 2019/07/19 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A207799-005 | PREGABALIN | ALKEM LABORATORIES LTD | CAPSULE | ORAL | PREGABALIN: 225MG | 2019/07/19 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A207799-006 | PREGABALIN | ALKEM LABORATORIES LTD | CAPSULE | ORAL | PREGABALIN: 300MG | 2019/07/19 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A207799-007 | PREGABALIN | ALKEM LABORATORIES LTD | CAPSULE | ORAL | PREGABALIN: 25MG | 2019/09/30 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A207799-008 | PREGABALIN | ALKEM LABORATORIES LTD | CAPSULE | ORAL | PREGABALIN: 50MG | 2019/09/30 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A207883-001 | PREGABALIN | PRINSTON PHARMACEUTICAL INC | CAPSULE | ORAL | PREGABALIN: 25MG | 2022/09/01 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A207883-002 | PREGABALIN | PRINSTON PHARMACEUTICAL INC | CAPSULE | ORAL | PREGABALIN: 50MG | 2022/09/01 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A207883-003 | PREGABALIN | PRINSTON PHARMACEUTICAL INC | CAPSULE | ORAL | PREGABALIN: 75MG | 2022/09/01 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A207883-004 | PREGABALIN | PRINSTON PHARMACEUTICAL INC | CAPSULE | ORAL | PREGABALIN: 100MG | 2022/09/01 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A207883-005 | PREGABALIN | PRINSTON PHARMACEUTICAL INC | CAPSULE | ORAL | PREGABALIN: 150MG | 2022/09/01 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A207883-006 | PREGABALIN | PRINSTON PHARMACEUTICAL INC | CAPSULE | ORAL | PREGABALIN: 200MG | 2022/09/01 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A207883-007 | PREGABALIN | PRINSTON PHARMACEUTICAL INC | CAPSULE | ORAL | PREGABALIN: 225MG | 2022/09/01 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A207883-008 | PREGABALIN | PRINSTON PHARMACEUTICAL INC | CAPSULE | ORAL | PREGABALIN: 300MG | 2022/09/01 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A208113-001 | PREGABALIN | REGCON HOLDINGS LLC | CAPSULE | ORAL | PREGABALIN: 25MG | 2024/05/17 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A208113-002 | PREGABALIN | REGCON HOLDINGS LLC | CAPSULE | ORAL | PREGABALIN: 50MG | 2024/05/17 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A208113-003 | PREGABALIN | REGCON HOLDINGS LLC | CAPSULE | ORAL | PREGABALIN: 150MG | 2024/05/17 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A208113-004 | PREGABALIN | REGCON HOLDINGS LLC | CAPSULE | ORAL | PREGABALIN: 75MG | 2024/05/17 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A208113-005 | PREGABALIN | REGCON HOLDINGS LLC | CAPSULE | ORAL | PREGABALIN: 100MG | 2024/05/17 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A208113-006 | PREGABALIN | REGCON HOLDINGS LLC | CAPSULE | ORAL | PREGABALIN: 200MG | 2024/05/17 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A208113-007 | PREGABALIN | REGCON HOLDINGS LLC | CAPSULE | ORAL | PREGABALIN: 225MG | 2024/05/17 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A208113-008 | PREGABALIN | REGCON HOLDINGS LLC | CAPSULE | ORAL | PREGABALIN: 300MG | 2024/05/17 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A208677-001 | PREGABALIN | SCIEGEN PHARMACEUTICALS INC | CAPSULE | ORAL | PREGABALIN: 25MG | 2019/07/19 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A208677-002 | PREGABALIN | SCIEGEN PHARMACEUTICALS INC | CAPSULE | ORAL | PREGABALIN: 50MG | 2019/07/19 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A208677-003 | PREGABALIN | SCIEGEN PHARMACEUTICALS INC | CAPSULE | ORAL | PREGABALIN: 75MG | 2019/07/19 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A208677-004 | PREGABALIN | SCIEGEN PHARMACEUTICALS INC | CAPSULE | ORAL | PREGABALIN: 100MG | 2019/07/19 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A208677-005 | PREGABALIN | SCIEGEN PHARMACEUTICALS INC | CAPSULE | ORAL | PREGABALIN: 150MG | 2019/07/19 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A208677-006 | PREGABALIN | SCIEGEN PHARMACEUTICALS INC | CAPSULE | ORAL | PREGABALIN: 200MG | 2019/07/19 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A208677-007 | PREGABALIN | SCIEGEN PHARMACEUTICALS INC | CAPSULE | ORAL | PREGABALIN: 225MG | 2019/07/19 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A208677-008 | PREGABALIN | SCIEGEN PHARMACEUTICALS INC | CAPSULE | ORAL | PREGABALIN: 300MG | 2019/07/19 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A209357-001 | PREGABALIN | MSN LABORATORIES PRIVATE LTD | CAPSULE | ORAL | PREGABALIN: 25MG | 2019/07/19 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A209357-002 | PREGABALIN | MSN LABORATORIES PRIVATE LTD | CAPSULE | ORAL | PREGABALIN: 50MG | 2019/07/19 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A209357-003 | PREGABALIN | MSN LABORATORIES PRIVATE LTD | CAPSULE | ORAL | PREGABALIN: 75MG | 2019/07/19 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A209357-004 | PREGABALIN | MSN LABORATORIES PRIVATE LTD | CAPSULE | ORAL | PREGABALIN: 100MG | 2019/07/19 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A209357-005 | PREGABALIN | MSN LABORATORIES PRIVATE LTD | CAPSULE | ORAL | PREGABALIN: 150MG | 2019/07/19 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A209357-006 | PREGABALIN | MSN LABORATORIES PRIVATE LTD | CAPSULE | ORAL | PREGABALIN: 200MG | 2019/07/19 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A209357-007 | PREGABALIN | MSN LABORATORIES PRIVATE LTD | CAPSULE | ORAL | PREGABALIN: 225MG | 2019/07/19 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A209357-008 | PREGABALIN | MSN LABORATORIES PRIVATE LTD | CAPSULE | ORAL | PREGABALIN: 300MG | 2019/07/19 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A209530-001 | PREGABALIN | JUBILANT GENERICS LTD | CAPSULE | ORAL | PREGABALIN: 25MG | 2025/05/20 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A209530-002 | PREGABALIN | JUBILANT GENERICS LTD | CAPSULE | ORAL | PREGABALIN: 50MG | 2025/05/20 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A209530-003 | PREGABALIN | JUBILANT GENERICS LTD | CAPSULE | ORAL | PREGABALIN: 75MG | 2025/05/20 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A209530-004 | PREGABALIN | JUBILANT GENERICS LTD | CAPSULE | ORAL | PREGABALIN: 100MG | 2025/05/20 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A209530-005 | PREGABALIN | JUBILANT GENERICS LTD | CAPSULE | ORAL | PREGABALIN: 150MG | 2025/05/20 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A209530-006 | PREGABALIN | JUBILANT GENERICS LTD | CAPSULE | ORAL | PREGABALIN: 200MG | 2025/05/20 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A209530-007 | PREGABALIN | JUBILANT GENERICS LTD | CAPSULE | ORAL | PREGABALIN: 225MG | 2025/05/20 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A209530-008 | PREGABALIN | JUBILANT GENERICS LTD | CAPSULE | ORAL | PREGABALIN: 300MG | 2025/05/20 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A209664-001 | PREGABALIN | DR REDDYS LABORATORIES LTD | CAPSULE | ORAL | PREGABALIN: 25MG | 2019/07/19 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A209664-002 | PREGABALIN | DR REDDYS LABORATORIES LTD | CAPSULE | ORAL | PREGABALIN: 50MG | 2019/07/19 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A209664-003 | PREGABALIN | DR REDDYS LABORATORIES LTD | CAPSULE | ORAL | PREGABALIN: 75MG | 2019/07/19 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A209664-004 | PREGABALIN | DR REDDYS LABORATORIES LTD | CAPSULE | ORAL | PREGABALIN: 100MG | 2019/07/19 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A209664-005 | PREGABALIN | DR REDDYS LABORATORIES LTD | CAPSULE | ORAL | PREGABALIN: 150MG | 2019/07/19 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A209664-006 | PREGABALIN | DR REDDYS LABORATORIES LTD | CAPSULE | ORAL | PREGABALIN: 200MG | 2019/07/19 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A209664-007 | PREGABALIN | DR REDDYS LABORATORIES LTD | CAPSULE | ORAL | PREGABALIN: 225MG | 2019/07/19 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A209664-008 | PREGABALIN | DR REDDYS LABORATORIES LTD | CAPSULE | ORAL | PREGABALIN: 300MG | 2019/07/19 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A209743-001 | PREGABALIN | AMNEAL PHARMACEUTICALS CO GMBH | CAPSULE | ORAL | PREGABALIN: 25MG | 2019/07/19 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A209743-002 | PREGABALIN | AMNEAL PHARMACEUTICALS CO GMBH | CAPSULE | ORAL | PREGABALIN: 50MG | 2019/07/19 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A209743-003 | PREGABALIN | AMNEAL PHARMACEUTICALS CO GMBH | CAPSULE | ORAL | PREGABALIN: 75MG | 2019/07/19 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A209743-004 | PREGABALIN | AMNEAL PHARMACEUTICALS CO GMBH | CAPSULE | ORAL | PREGABALIN: 100MG | 2019/07/19 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A209743-005 | PREGABALIN | AMNEAL PHARMACEUTICALS CO GMBH | CAPSULE | ORAL | PREGABALIN: 150MG | 2019/07/19 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A209743-006 | PREGABALIN | AMNEAL PHARMACEUTICALS CO GMBH | CAPSULE | ORAL | PREGABALIN: 200MG | 2019/07/19 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A209743-007 | PREGABALIN | AMNEAL PHARMACEUTICALS CO GMBH | CAPSULE | ORAL | PREGABALIN: 225MG | 2019/07/19 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A209743-008 | PREGABALIN | AMNEAL PHARMACEUTICALS CO GMBH | CAPSULE | ORAL | PREGABALIN: 300MG | 2019/07/19 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A209883-001 | PREGABALIN | STRIDES PHARMA GLOBAL PTE LTD | CAPSULE | ORAL | PREGABALIN: 25MG | 2024/01/24 | N / N | DISCONTINUED | openFDA ↗ |
| A209883-002 | PREGABALIN | STRIDES PHARMA GLOBAL PTE LTD | CAPSULE | ORAL | PREGABALIN: 50MG | 2024/01/24 | N / N | DISCONTINUED | openFDA ↗ |
| A209883-003 | PREGABALIN | STRIDES PHARMA GLOBAL PTE LTD | CAPSULE | ORAL | PREGABALIN: 75MG | 2024/01/24 | N / N | DISCONTINUED | openFDA ↗ |
| A209883-004 | PREGABALIN | STRIDES PHARMA GLOBAL PTE LTD | CAPSULE | ORAL | PREGABALIN: 100MG | 2024/01/24 | N / N | DISCONTINUED | openFDA ↗ |
| A209883-005 | PREGABALIN | STRIDES PHARMA GLOBAL PTE LTD | CAPSULE | ORAL | PREGABALIN: 150MG | 2024/01/24 | N / N | DISCONTINUED | openFDA ↗ |
| A209883-006 | PREGABALIN | STRIDES PHARMA GLOBAL PTE LTD | CAPSULE | ORAL | PREGABALIN: 200MG | 2024/01/24 | N / N | DISCONTINUED | openFDA ↗ |
| A209883-007 | PREGABALIN | STRIDES PHARMA GLOBAL PTE LTD | CAPSULE | ORAL | PREGABALIN: 225MG | 2024/01/24 | N / N | DISCONTINUED | openFDA ↗ |
| A209883-008 | PREGABALIN | STRIDES PHARMA GLOBAL PTE LTD | CAPSULE | ORAL | PREGABALIN: 300MG | 2024/01/24 | N / N | DISCONTINUED | openFDA ↗ |
| A210432-001 | PREGABALIN | RISING PHARMA HOLDINGS INC | CAPSULE | ORAL | PREGABALIN: 25MG | 2019/07/19 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A210432-002 | PREGABALIN | RISING PHARMA HOLDINGS INC | CAPSULE | ORAL | PREGABALIN: 50MG | 2019/07/19 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A210432-003 | PREGABALIN | RISING PHARMA HOLDINGS INC | CAPSULE | ORAL | PREGABALIN: 75MG | 2019/07/19 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A210432-004 | PREGABALIN | RISING PHARMA HOLDINGS INC | CAPSULE | ORAL | PREGABALIN: 100MG | 2019/07/19 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A210432-005 | PREGABALIN | RISING PHARMA HOLDINGS INC | CAPSULE | ORAL | PREGABALIN: 150MG | 2019/07/19 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A210432-006 | PREGABALIN | RISING PHARMA HOLDINGS INC | CAPSULE | ORAL | PREGABALIN: 200MG | 2019/07/19 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A210432-007 | PREGABALIN | RISING PHARMA HOLDINGS INC | CAPSULE | ORAL | PREGABALIN: 225MG | 2019/07/19 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A210432-008 | PREGABALIN | RISING PHARMA HOLDINGS INC | CAPSULE | ORAL | PREGABALIN: 300MG | 2019/07/19 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A210585-001 | PREGABALIN | SOMERSET THERAPEUTICS LLC | CAPSULE | ORAL | PREGABALIN: 50MG | 2019/12/26 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A210585-002 | PREGABALIN | SOMERSET THERAPEUTICS LLC | CAPSULE | ORAL | PREGABALIN: 75MG | 2019/12/26 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A210585-003 | PREGABALIN | SOMERSET THERAPEUTICS LLC | CAPSULE | ORAL | PREGABALIN: 100MG | 2019/12/26 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A210585-004 | PREGABALIN | SOMERSET THERAPEUTICS LLC | CAPSULE | ORAL | PREGABALIN: 150MG | 2019/12/26 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A210585-005 | PREGABALIN | SOMERSET THERAPEUTICS LLC | CAPSULE | ORAL | PREGABALIN: 200MG | 2019/12/26 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A210585-006 | PREGABALIN | SOMERSET THERAPEUTICS LLC | CAPSULE | ORAL | PREGABALIN: 300MG | 2019/12/26 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A210891-001 | PREGABALIN | PHARMOBEDIENT CONSULTING LLC | CAPSULE | ORAL | PREGABALIN: 75MG | 2019/09/30 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A210891-002 | PREGABALIN | PHARMOBEDIENT CONSULTING LLC | CAPSULE | ORAL | PREGABALIN: 300MG | 2019/09/30 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A211384-001 | PREGABALIN | INVAGEN PHARMACEUTICALS INC | CAPSULE | ORAL | PREGABALIN: 25MG | 2019/07/19 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A211384-002 | PREGABALIN | INVAGEN PHARMACEUTICALS INC | CAPSULE | ORAL | PREGABALIN: 50MG | 2019/07/19 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A211384-003 | PREGABALIN | INVAGEN PHARMACEUTICALS INC | CAPSULE | ORAL | PREGABALIN: 75MG | 2019/07/19 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A211384-004 | PREGABALIN | INVAGEN PHARMACEUTICALS INC | CAPSULE | ORAL | PREGABALIN: 100MG | 2019/07/19 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A211384-005 | PREGABALIN | INVAGEN PHARMACEUTICALS INC | CAPSULE | ORAL | PREGABALIN: 150MG | 2019/07/19 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A211384-006 | PREGABALIN | INVAGEN PHARMACEUTICALS INC | CAPSULE | ORAL | PREGABALIN: 200MG | 2019/07/19 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A211384-007 | PREGABALIN | INVAGEN PHARMACEUTICALS INC | CAPSULE | ORAL | PREGABALIN: 225MG | 2019/07/19 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A211384-008 | PREGABALIN | INVAGEN PHARMACEUTICALS INC | CAPSULE | ORAL | PREGABALIN: 300MG | 2019/07/19 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A211685-001 | PREGABALIN | APOTEX INC | CAPSULE | ORAL | PREGABALIN: 25MG | 2021/07/07 | N / N | DISCONTINUED | openFDA ↗ |
| A211685-002 | PREGABALIN | APOTEX INC | CAPSULE | ORAL | PREGABALIN: 50MG | 2021/07/07 | N / N | DISCONTINUED | openFDA ↗ |
| A211685-003 | PREGABALIN | APOTEX INC | CAPSULE | ORAL | PREGABALIN: 75MG | 2021/07/07 | N / N | DISCONTINUED | openFDA ↗ |
| A211685-004 | PREGABALIN | APOTEX INC | CAPSULE | ORAL | PREGABALIN: 100MG | 2021/07/07 | N / N | DISCONTINUED | openFDA ↗ |
| A211685-005 | PREGABALIN | APOTEX INC | CAPSULE | ORAL | PREGABALIN: 150MG | 2021/07/07 | N / N | DISCONTINUED | openFDA ↗ |
| A211685-006 | PREGABALIN | APOTEX INC | CAPSULE | ORAL | PREGABALIN: 200MG | 2021/07/07 | N / N | DISCONTINUED | openFDA ↗ |
| A211685-007 | PREGABALIN | APOTEX INC | CAPSULE | ORAL | PREGABALIN: 225MG | 2021/07/07 | N / N | DISCONTINUED | openFDA ↗ |
| A211685-008 | PREGABALIN | APOTEX INC | CAPSULE | ORAL | PREGABALIN: 300MG | 2021/07/07 | N / N | DISCONTINUED | openFDA ↗ |
| A212280-001 | PREGABALIN | CIPLA LTD | CAPSULE | ORAL | PREGABALIN: 25MG | 2020/01/10 | N / N | DISCONTINUED | openFDA ↗ |
| A212280-002 | PREGABALIN | CIPLA LTD | CAPSULE | ORAL | PREGABALIN: 50MG | 2020/01/10 | N / N | DISCONTINUED | openFDA ↗ |
| A212280-003 | PREGABALIN | CIPLA LTD | CAPSULE | ORAL | PREGABALIN: 75MG | 2020/01/10 | N / N | DISCONTINUED | openFDA ↗ |
| A212280-004 | PREGABALIN | CIPLA LTD | CAPSULE | ORAL | PREGABALIN: 100MG | 2020/01/10 | N / N | DISCONTINUED | openFDA ↗ |
| A212280-005 | PREGABALIN | CIPLA LTD | CAPSULE | ORAL | PREGABALIN: 150MG | 2020/01/10 | N / N | DISCONTINUED | openFDA ↗ |
| A212280-006 | PREGABALIN | CIPLA LTD | CAPSULE | ORAL | PREGABALIN: 200MG | 2020/01/10 | N / N | DISCONTINUED | openFDA ↗ |
| A212280-007 | PREGABALIN | CIPLA LTD | CAPSULE | ORAL | PREGABALIN: 225MG | 2020/01/10 | N / N | DISCONTINUED | openFDA ↗ |
| A212280-008 | PREGABALIN | CIPLA LTD | CAPSULE | ORAL | PREGABALIN: 300MG | 2020/01/10 | N / N | DISCONTINUED | openFDA ↗ |
| A212865-001 | PREGABALIN | CHARTWELL RX SCIENCES LLC | CAPSULE | ORAL | PREGABALIN: 50MG | 2020/03/20 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A212865-002 | PREGABALIN | CHARTWELL RX SCIENCES LLC | CAPSULE | ORAL | PREGABALIN: 75MG | 2020/03/20 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A212865-003 | PREGABALIN | CHARTWELL RX SCIENCES LLC | CAPSULE | ORAL | PREGABALIN: 100MG | 2020/03/20 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A212865-004 | PREGABALIN | CHARTWELL RX SCIENCES LLC | CAPSULE | ORAL | PREGABALIN: 150MG | 2020/03/20 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A212988-001 | PREGABALIN | PHARMAZONE | CAPSULE | ORAL | PREGABALIN: 25MG | 2022/03/08 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A212988-002 | PREGABALIN | PHARMAZONE | CAPSULE | ORAL | PREGABALIN: 50MG | 2022/03/08 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A212988-003 | PREGABALIN | PHARMAZONE | CAPSULE | ORAL | PREGABALIN: 75MG | 2022/03/08 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A212988-004 | PREGABALIN | PHARMAZONE | CAPSULE | ORAL | PREGABALIN: 100MG | 2022/03/08 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A212988-005 | PREGABALIN | PHARMAZONE | CAPSULE | ORAL | PREGABALIN: 150MG | 2022/03/08 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A212988-006 | PREGABALIN | PHARMAZONE | CAPSULE | ORAL | PREGABALIN: 200MG | 2022/03/08 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A212988-007 | PREGABALIN | PHARMAZONE | CAPSULE | ORAL | PREGABALIN: 225MG | 2022/03/08 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A212988-008 | PREGABALIN | PHARMAZONE | CAPSULE | ORAL | PREGABALIN: 300MG | 2022/03/08 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A213423-001 | PREGABALIN | CREEKWOOD PHARMACEUTICALS LLC | CAPSULE | ORAL | PREGABALIN: 25MG | 2020/03/23 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A213423-002 | PREGABALIN | CREEKWOOD PHARMACEUTICALS LLC | CAPSULE | ORAL | PREGABALIN: 50MG | 2020/03/23 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A213423-003 | PREGABALIN | CREEKWOOD PHARMACEUTICALS LLC | CAPSULE | ORAL | PREGABALIN: 75MG | 2020/03/23 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A213423-004 | PREGABALIN | CREEKWOOD PHARMACEUTICALS LLC | CAPSULE | ORAL | PREGABALIN: 100MG | 2020/03/23 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A213423-005 | PREGABALIN | CREEKWOOD PHARMACEUTICALS LLC | CAPSULE | ORAL | PREGABALIN: 150MG | 2020/03/23 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A213423-006 | PREGABALIN | CREEKWOOD PHARMACEUTICALS LLC | CAPSULE | ORAL | PREGABALIN: 200MG | 2020/03/23 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A213423-007 | PREGABALIN | CREEKWOOD PHARMACEUTICALS LLC | CAPSULE | ORAL | PREGABALIN: 225MG | 2020/03/23 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A213423-008 | PREGABALIN | CREEKWOOD PHARMACEUTICALS LLC | CAPSULE | ORAL | PREGABALIN: 300MG | 2020/03/23 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A214322-001 | PREGABALIN | TRIS PHARMA INC | CAPSULE | ORAL | PREGABALIN: 50MG | 2021/07/15 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A214322-002 | PREGABALIN | TRIS PHARMA INC | CAPSULE | ORAL | PREGABALIN: 75MG | 2021/07/15 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A214322-003 | PREGABALIN | TRIS PHARMA INC | CAPSULE | ORAL | PREGABALIN: 100MG | 2021/07/15 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A214322-004 | PREGABALIN | TRIS PHARMA INC | CAPSULE | ORAL | PREGABALIN: 150MG | 2021/07/15 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A214322-005 | PREGABALIN | TRIS PHARMA INC | CAPSULE | ORAL | PREGABALIN: 200MG | 2021/07/15 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A214322-006 | PREGABALIN | TRIS PHARMA INC | CAPSULE | ORAL | PREGABALIN: 225MG | 2021/07/15 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A214322-007 | PREGABALIN | TRIS PHARMA INC | CAPSULE | ORAL | PREGABALIN: 300MG | 2021/07/15 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A214322-008 | PREGABALIN | TRIS PHARMA INC | CAPSULE | ORAL | PREGABALIN: 25MG | 2024/09/26 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A215755-001 | PREGABALIN | STRIDES PHARMA GLOBAL PTE LTD | CAPSULE | ORAL | PREGABALIN: 25MG | 2023/04/26 | N / N | DISCONTINUED | openFDA ↗ |
| A215755-002 | PREGABALIN | STRIDES PHARMA GLOBAL PTE LTD | CAPSULE | ORAL | PREGABALIN: 50MG | 2023/04/26 | N / N | DISCONTINUED | openFDA ↗ |
| A215755-003 | PREGABALIN | STRIDES PHARMA GLOBAL PTE LTD | CAPSULE | ORAL | PREGABALIN: 75MG | 2023/04/26 | N / N | DISCONTINUED | openFDA ↗ |
| A215755-004 | PREGABALIN | STRIDES PHARMA GLOBAL PTE LTD | CAPSULE | ORAL | PREGABALIN: 100MG | 2023/04/26 | N / N | DISCONTINUED | openFDA ↗ |
| A215755-005 | PREGABALIN | STRIDES PHARMA GLOBAL PTE LTD | CAPSULE | ORAL | PREGABALIN: 150MG | 2023/04/26 | N / N | DISCONTINUED | openFDA ↗ |
| A215755-006 | PREGABALIN | STRIDES PHARMA GLOBAL PTE LTD | CAPSULE | ORAL | PREGABALIN: 200MG | 2023/04/26 | N / N | DISCONTINUED | openFDA ↗ |
| A215755-007 | PREGABALIN | STRIDES PHARMA GLOBAL PTE LTD | CAPSULE | ORAL | PREGABALIN: 225MG | 2023/04/26 | N / N | DISCONTINUED | openFDA ↗ |
| A215755-008 | PREGABALIN | STRIDES PHARMA GLOBAL PTE LTD | CAPSULE | ORAL | PREGABALIN: 300MG | 2023/04/26 | N / N | DISCONTINUED | openFDA ↗ |
| A216197-001 | PREGABALIN | PHARMAZONE | CAPSULE | ORAL | PREGABALIN: 25MG | 2022/07/18 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A216197-002 | PREGABALIN | PHARMAZONE | CAPSULE | ORAL | PREGABALIN: 50MG | 2022/07/18 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A216197-003 | PREGABALIN | PHARMAZONE | CAPSULE | ORAL | PREGABALIN: 75MG | 2022/07/18 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A216197-004 | PREGABALIN | PHARMAZONE | CAPSULE | ORAL | PREGABALIN: 100MG | 2022/07/18 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A216197-005 | PREGABALIN | PHARMAZONE | CAPSULE | ORAL | PREGABALIN: 150MG | 2022/07/18 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A216197-006 | PREGABALIN | PHARMAZONE | CAPSULE | ORAL | PREGABALIN: 200MG | 2022/07/18 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A216197-007 | PREGABALIN | PHARMAZONE | CAPSULE | ORAL | PREGABALIN: 225MG | 2022/07/18 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A216197-008 | PREGABALIN | PHARMAZONE | CAPSULE | ORAL | PREGABALIN: 300MG | 2022/07/18 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A218529-001 | PREGABALIN | CAPLIN STERILES LTD | CAPSULE | ORAL | PREGABALIN: 25MG | 2026/02/24 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A218529-002 | PREGABALIN | CAPLIN STERILES LTD | CAPSULE | ORAL | PREGABALIN: 50MG | 2026/02/24 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A218529-003 | PREGABALIN | CAPLIN STERILES LTD | CAPSULE | ORAL | PREGABALIN: 75MG | 2026/02/24 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A218529-004 | PREGABALIN | CAPLIN STERILES LTD | CAPSULE | ORAL | PREGABALIN: 100MG | 2026/02/24 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A218529-005 | PREGABALIN | CAPLIN STERILES LTD | CAPSULE | ORAL | PREGABALIN: 150MG | 2026/02/24 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A218529-006 | PREGABALIN | CAPLIN STERILES LTD | CAPSULE | ORAL | PREGABALIN: 200MG | 2026/02/24 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A218529-007 | PREGABALIN | CAPLIN STERILES LTD | CAPSULE | ORAL | PREGABALIN: 225MG | 2026/02/24 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A218529-008 | PREGABALIN | CAPLIN STERILES LTD | CAPSULE | ORAL | PREGABALIN: 300MG | 2026/02/24 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A219593-001 | PREGABALIN | UNICHEM LABORATORIES LTD | CAPSULE | ORAL | PREGABALIN: 25MG | 2026/04/30 | N / N | DISCONTINUED | openFDA ↗ |
| A219593-002 | PREGABALIN | UNICHEM LABORATORIES LTD | CAPSULE | ORAL | PREGABALIN: 50MG | 2026/04/30 | N / N | DISCONTINUED | openFDA ↗ |
| A219593-003 | PREGABALIN | UNICHEM LABORATORIES LTD | CAPSULE | ORAL | PREGABALIN: 75MG | 2026/04/30 | N / N | DISCONTINUED | openFDA ↗ |
| A219593-004 | PREGABALIN | UNICHEM LABORATORIES LTD | CAPSULE | ORAL | PREGABALIN: 100MG | 2026/04/30 | N / N | DISCONTINUED | openFDA ↗ |
| A219593-005 | PREGABALIN | UNICHEM LABORATORIES LTD | CAPSULE | ORAL | PREGABALIN: 150MG | 2026/04/30 | N / N | DISCONTINUED | openFDA ↗ |
| A219593-006 | PREGABALIN | UNICHEM LABORATORIES LTD | CAPSULE | ORAL | PREGABALIN: 200MG | 2026/04/30 | N / N | DISCONTINUED | openFDA ↗ |
| A219593-007 | PREGABALIN | UNICHEM LABORATORIES LTD | CAPSULE | ORAL | PREGABALIN: 225MG | 2026/04/30 | N / N | DISCONTINUED | openFDA ↗ |
| A219593-008 | PREGABALIN | UNICHEM LABORATORIES LTD | CAPSULE | ORAL | PREGABALIN: 300MG | 2026/04/30 | N / N | DISCONTINUED | openFDA ↗ |
| N021446-001 | LYRICA | UPJOHN US 2 LLC | CAPSULE | ORAL | PREGABALIN: 25MG | 2004/12/30 | Y / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| N021446-002 | LYRICA | UPJOHN US 2 LLC | CAPSULE | ORAL | PREGABALIN: 50MG | 2004/12/30 | Y / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| N021446-003 | LYRICA | UPJOHN US 2 LLC | CAPSULE | ORAL | PREGABALIN: 75MG | 2004/12/30 | Y / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| N021446-004 | LYRICA | UPJOHN US 2 LLC | CAPSULE | ORAL | PREGABALIN: 100MG | 2004/12/30 | Y / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| N021446-005 | LYRICA | UPJOHN US 2 LLC | CAPSULE | ORAL | PREGABALIN: 150MG | 2004/12/30 | Y / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| N021446-006 | LYRICA | UPJOHN US 2 LLC | CAPSULE | ORAL | PREGABALIN: 200MG | 2004/12/30 | Y / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| N021446-007 | LYRICA | UPJOHN US 2 LLC | CAPSULE | ORAL | PREGABALIN: 225MG | 2004/12/30 | Y / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| N021446-008 | LYRICA | UPJOHN US 2 LLC | CAPSULE | ORAL | PREGABALIN: 300MG | 2004/12/30 | Y / Y | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
Listed US patents
*PED rows, substance/product flags, use codes and delisting-request flags are retained without determining legal effect.
Latest listed patent expiration—
Substance patent expiration (DS flag)—
This column includes only source rows explicitly flagged DS. A PED row without that flag is not assigned one by this site.
| Application / product number | Patent number | Listed expiration | Substance / product flags | Use code | Delisting request | Official source |
|---|---|---|---|---|---|---|
| Not listed | ||||||
Exclusivity source records
FDA exclusivity code list ↗Latest exclusivity expiration: —
| Application / product number | Exclusivity code | Listed expiration | Official source |
|---|---|---|---|
| Not listed | |||
Chinese record details
Chinese product landscape ↗The four-zero filter applies only to matched rows: catalog holders, NHSA approval numbers, applications under review, and companies filing generics this year. Unmatched rows have no Chinese counts. Filings are counted by acceptance number and filing companies by first applicant. Strengths may have separate applications. Drug names are normalized only for width and whitespace; distinct generic names, dosage forms and combinations remain separate. Unstated strengths are marked. Company counts from different sources must not be added together.
Catalog holders 34
| Company (original) | Identifier (original) | Source date | Official source |
|---|---|---|---|
| Dong Bei Pharmaceutical Group Shenyang Di Yi Pharmaceutical Co., Ltd. romanized | 国药准字H2026498275mg | 2026/06/30 | Official source ↗ |
| Dong Bei Pharmaceutical Group Shenyang Di Yi Pharmaceutical Co., Ltd. romanized | 国药准字H20264983150mg | 2026/06/30 | Official source ↗ |
| Hui Zhi Pharmaceutical (Da Lian) Co., Ltd. romanized | 国药准字H2026311175mg | 2026/01/14 | Official source ↗ |
| Hui Zhi Pharmaceutical (Da Lian) Co., Ltd. romanized | 国药准字H20263112150mg | 2026/01/14 | Official source ↗ |
| Da Tong Pharmaceutical (Zhongguo) Co., Ltd. romanized | 国药准字H20253195150mg | 2025/01/14 | Official source ↗ |
| Da Tong Pharmaceutical (Zhongguo) Co., Ltd. romanized | 国药准字H2025319475mg | 2025/01/14 | Official source ↗ |
| Zhejiang AngLiKang Pharmaceutical CO.,LTD. | 国药准字H2025318075mg | 2025/01/14 | Official source ↗ |
| Zhejiang AngLiKang Pharmaceutical CO.,LTD. | 国药准字H20253179150mg | 2025/01/14 | Official source ↗ |
| Hunan Sai Long Pharma Co., Ltd. romanized | 国药准字H2024728075mg | 2024/11/07 | Official source ↗ |
| Fujian Sheng Bao Nuo Pharmaceuticals Research and Development Co., Ltd. romanized | 国药准字H20249116150mg | 2024/10/22 | Official source ↗ |
| Fujian Sheng Bao Nuo Pharmaceuticals Research and Development Co., Ltd. romanized | 国药准字H2024911575mg | 2024/10/22 | Official source ↗ |
| Anhui Jiu Zhou Fang Yuan Pharmaceutical Co., Ltd. romanized | 国药准字H2024908275mg | 2024/10/16 | Official source ↗ |
| Jiangsu En Hua Pharma Co., Ltd. romanized | 国药准字H2024397975mg | 2024/06/11 | Official source ↗ |
| SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED | 国药准字H2024397775mg | 2024/06/11 | Official source ↗ |
| SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED | 国药准字H20243976150mg | 2024/06/11 | Official source ↗ |
| Ningbo Shuang Cheng Pharma Co., Ltd. romanized | 国药准字H2024333075mg | 2024/03/12 | Official source ↗ |
| Ningbo Shuang Cheng Pharma Co., Ltd. romanized | 国药准字H20243331300mg | 2024/03/12 | Official source ↗ |
| Ao Mei Pharmaceutical (Hainan) Co., Ltd. romanized | 国药准字H2024332975mg | 2024/03/12 | Official source ↗ |
| Ao Mei Pharmaceutical (Hainan) Co., Ltd. romanized | 国药准字H20243328150mg | 2024/03/12 | Official source ↗ |
| Chongqing Pharmaceuticals (Group) Co., Ltd. romanized | 国药准字H2024330475mg | 2024/03/05 | Official source ↗ |
| Chongqing Pharmaceuticals (Group) Co., Ltd. romanized | 国药准字H20243305150mg | 2024/03/05 | Official source ↗ |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243210100mg | 2024/02/23 | Official source ↗ |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H2024321175mg | 2024/02/23 | Official source ↗ |
| Hunan Sai Long Pharma Co., Ltd. romanized | 国药准字H20243261150mg | 2024/02/23 | Official source ↗ |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20234482150mg | 2023/11/14 | Official source ↗ |
| Shandong Dan Hong Pharmaceutical Co., Ltd. romanized | 国药准字H2023401675mg | 2023/08/08 | Official source ↗ |
| Shandong Dan Hong Pharmaceutical Co., Ltd. romanized | 国药准字H20234017150mg | 2023/08/08 | Official source ↗ |
| Dr. Reddy’s Laboratories Limited | 国药准字HJ2023009775mg | 2023/08/01 | Official source ↗ |
| Dr. Reddy’s Laboratories Limited | 国药准字HJ20230098150mg | 2023/08/01 | Official source ↗ |
| Sichuan Pharmaceutical Formulations Co., Ltd. romanized | 国药准字H2023392275mg | 2023/07/11 | Official source ↗ |
| Sichuan Pharmaceutical Formulations Co., Ltd. romanized | 国药准字H20233923150mg | 2023/07/11 | Official source ↗ |
| YaoPharma Co., Ltd. | 国药准字H2023355775mg | 2023/05/19 | Official source ↗ |
| YaoPharma Co., Ltd. | 国药准字H20233558150mg | 2023/05/19 | Official source ↗ |
| TC Pharmaceuticals (Jiangsu) Co., Ltd | 国药准字H2023325575mg | 2023/03/07 | Official source ↗ |
| Guangdong Jin Cheng Jin Su Pharmaceutical Co., Ltd. romanized | 国药准字H2023316775mg | 2023/02/14 | Official source ↗ |
| Guangdong Jin Cheng Jin Su Pharmaceutical Co., Ltd. romanized | 国药准字H20233165150mg | 2023/02/14 | Official source ↗ |
| Guangdong Jin Cheng Jin Su Pharmaceutical Co., Ltd. romanized | 国药准字H20233166100mg | 2023/02/14 | Official source ↗ |
| Sichuan Ke Lun Drug Research Institute Co., Ltd. romanized | 国药准字H20233134150mg | 2023/02/07 | Official source ↗ |
| Sichuan Ke Lun Drug Research Institute Co., Ltd. romanized | 国药准字H2023313375mg | 2023/02/07 | Official source ↗ |
| Ya Bao Pharma Tai Yuan Pharmaceutical Co., Ltd. romanized | 国药准字H2022395775mg | 2022/12/30 | Official source ↗ |
| Ya Bao Pharma Tai Yuan Pharmaceutical Co., Ltd. romanized | 国药准字H20223958150mg | 2022/12/30 | Official source ↗ |
| Guangdong Jiu Rui Technology Kai Fa Co., Ltd. romanized | 国药准字H20223713100mg | 2022/09/30 | Official source ↗ |
| Guangdong Jiu Rui Technology Kai Fa Co., Ltd. romanized | 国药准字H2022371275mg | 2022/09/30 | Official source ↗ |
| Yang Zi Jiang Pharma Group Nanjing Hai Ling Pharma Co., Ltd. romanized | 国药准字H20223587150mg | 2022/08/10 | Official source ↗ |
| Yang Zi Jiang Pharma Group Nanjing Hai Ling Pharma Co., Ltd. romanized | 国药准字H2022358875mg | 2022/08/10 | Official source ↗ |
| Tian Di Heng Yi Pharmaceutical Co., Ltd. romanized | 国药准字H2022330575mg | 2022/05/10 | Official source ↗ |
| Tian Di Heng Yi Pharmaceutical Co., Ltd. romanized | 国药准字H20223306150mg | 2022/05/10 | Official source ↗ |
| Tian Di Heng Yi Pharmaceutical Co., Ltd. romanized | 国药准字H20223307300mg | 2022/05/10 | Official source ↗ |
| Hainan Jin Rui Pharmaceutical Co., Ltd. romanized | 国药准字H2022322075mg | 2022/04/12 | Official source ↗ |
| ZHE JIANG HUA HAI PHARMACEUTICALCO.,LTD. | 国药准字H2021376575mg | 2021/09/30 | Official source ↗ |
| ZHE JIANG HUA HAI PHARMACEUTICALCO.,LTD. | 国药准字H20213766100mg | 2021/09/30 | Official source ↗ |
| ZHE JIANG HUA HAI PHARMACEUTICALCO.,LTD. | 国药准字H20213767150mg | 2021/09/30 | Official source ↗ |
| Shijiazhuang Long Ze Pharmaceutical Co., Ltd. romanized | 国药准字H20213706150mg | 2021/09/07 | Official source ↗ |
| Shijiazhuang Long Ze Pharmaceutical Co., Ltd. romanized | 国药准字H2021370325mg | 2021/09/07 | Official source ↗ |
| Shijiazhuang Long Ze Pharmaceutical Co., Ltd. romanized | 国药准字H2021370250mg | 2021/09/07 | Official source ↗ |
| Shijiazhuang Long Ze Pharmaceutical Co., Ltd. romanized | 国药准字H20213705100mg | 2021/09/07 | Official source ↗ |
| Shijiazhuang Long Ze Pharmaceutical Co., Ltd. romanized | 国药准字H2021370475mg | 2021/09/07 | Official source ↗ |
| CSPC OUYI PHARMACEUTICAL CO., LTD. | 国药准字H2021344975mg | 2021/06/01 | Official source ↗ |
| CSPC OUYI PHARMACEUTICAL CO., LTD. | 国药准字H20213450150mg | 2021/06/01 | Official source ↗ |
| Hainan Wan Wei Pharmaceutical Co., Ltd. romanized | 国药准字H20213340150mg | 2021/05/11 | Official source ↗ |
| Hainan Wan Wei Pharmaceutical Co., Ltd. romanized | 国药准字H2021333975mg | 2021/05/11 | Official source ↗ |
| Ningbo Ke Er Kang Mei Nuo Hua Pharma Co., Ltd. romanized | 国药准字H20203640150mg | 2020/12/02 | Official source ↗ |
| Ningbo Ke Er Kang Mei Nuo Hua Pharma Co., Ltd. romanized | 国药准字H2020364175mg | 2020/12/02 | Official source ↗ |
| Chongqing Sai Wei Pharma Co., Ltd. romanized | 国药准字H20130064100mg | 2020/11/11 | Official source ↗ |
| Chongqing Sai Wei Pharma Co., Ltd. romanized | 国药准字H2013007375mg | 2020/11/11 | Official source ↗ |
| Hua Run Shuang He Pharma Co., Ltd. romanized | 国药准字H20203551150mg | 2020/11/04 | Official source ↗ |
| Hua Run Shuang He Pharma Co., Ltd. romanized | 国药准字H2020355075mg | 2020/11/04 | Official source ↗ |
| Qilu Pharmaceutical (Hainan) Co., Ltd | 国药准字H20203041150mg | 2020/02/20 | Official source ↗ |
| Qilu Pharmaceutical (Hainan) Co., Ltd | 国药准字H2020304075mg | 2020/02/20 | Official source ↗ |
| Pfizer Limited | H20150625300mg | 2010/05/07 | Official source ↗ |
| Pfizer Limited | H20150624200mg | 2010/05/07 | Official source ↗ |
| Pfizer Limited | H20150622150mg | 2010/05/07 | Official source ↗ |
| Pfizer Limited | H20150621100mg | 2010/05/07 | Official source ↗ |
| Pfizer Limited | H2015061975mg | 2010/05/07 | Official source ↗ |
| Pfizer Limited | H2015061850mg | 2010/05/07 | Official source ↗ |
| Pfizer Limited | H2015061725mg | 2010/05/07 | Official source ↗ |
NHSA approval numbers 70
| Company (original) | Identifier (original) | Source date | Official source |
|---|---|---|---|
| Chongqing Pharmaceuticals (Group) Co., Ltd. romanized | 国药准字H2024330475mg | — | Official source ↗ |
| Chongqing Sai Wei Pharma Co., Ltd. romanized | 国药准字H20130064100mg | — | Official source ↗ |
| Hunan Dong Ting Pharma Co., Ltd. romanized | 国药准字H2023355775mg | — | Official source ↗ |
| Upjohn EESV | 国药准字J20160022150mg | — | Official source ↗ |
| Jiangsu En Hua Pharma Co., Ltd. romanized | 国药准字H2024397975mg | — | Official source ↗ |
| Yang Zi Jiang Pharma Group Nanjing Hai Ling Pharma Co., Ltd. romanized | 国药准字H2022358875mg | — | Official source ↗ |
| De Quan Medicines (Jiangsu) Co., Ltd. romanized | 国药准字H2023325575mg | — | Official source ↗ |
| Sichuan Kelun Pharmaceutical Co., Ltd. | 国药准字H2023313375mg | — | Official source ↗ |
| Sichuan Pharmaceutical Formulations Co., Ltd. romanized | 国药准字H2023392275mg | — | Official source ↗ |
| CSPC OUYI PHARMACEUTICAL CO., LTD. | 国药准字H2021344975mg | — | Official source ↗ |
| Ya Bao Pharma Group Co., Ltd. romanized | 国药准字H2022395775mg | — | Official source ↗ |
| Shandong Dan Hong Pharmaceutical Co., Ltd. romanized | 国药准字H2023401675mg | — | Official source ↗ |
| SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED | 国药准字H20243976150mg | — | Official source ↗ |
| Ningbo Ke Er Kang Mei Nuo Hua Pharma Co., Ltd. romanized | 国药准字H2020364175mg | — | Official source ↗ |
| Zhejiang AngLiKang Pharmaceutical CO.,LTD. | 国药准字H2025318075mg | — | Official source ↗ |
| ZHE JIANG HUA HAI PHARMACEUTICALCO.,LTD. | 国药准字H2021376575mg | — | Official source ↗ |
| Guangdong Jiu Rui Technology Kai Fa Co., Ltd. romanized | 国药准字H2022371275mg | — | Official source ↗ |
| Ao Mei Pharmaceutical (Hainan) Co., Ltd. romanized | 国药准字H20243328150mg | — | Official source ↗ |
| Qi Lu Pharmaceutical (Hainan) Co., Ltd. romanized | 国药准字H2020304075mg | — | Official source ↗ |
| Dr.Reddy's Laboratories Limited | 国药准字HJ2023009775mg | — | Official source ↗ |
| Shijiazhuang Long Ze Pharmaceutical Co., Ltd. romanized | 国药准字H2021370325mg | — | Official source ↗ |
| Hainan Jin Rui Pharmaceutical Co., Ltd. romanized | 国药准字H2022322075mg | — | Official source ↗ |
| Hunan Bao Bao Tuan Pharma Co., Ltd. romanized | 国药准字H20243261150mg | — | Official source ↗ |
| Tian Di Heng Yi Pharmaceutical Co., Ltd. romanized | 国药准字H2022330575mg | — | Official source ↗ |
| Da Tong Pharmaceutical (Zhongguo) Co., Ltd. romanized | 国药准字H2025319475mg | — | Official source ↗ |
| Guangdong Jin Cheng Jin Su Pharmaceutical Co., Ltd. romanized | 国药准字H2023316775mg | — | Official source ↗ |
| Anhui Jiu Zhou Fang Yuan Pharmaceutical Co., Ltd. romanized | 国药准字H2024908275mg | — | Official source ↗ |
| Hua Run Shuang He Pharma Co., Ltd. romanized | 国药准字H2020355075mg | — | Official source ↗ |
| Guangdong Jin Cheng Jin Su Pharmaceutical Co., Ltd. romanized | 国药准字H20233165150mg | — | Official source ↗ |
| Hainan Wan Wei Pharmaceutical Co., Ltd. romanized | 国药准字H2021333975mg | — | Official source ↗ |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H2024321175mg | — | Official source ↗ |
| Sichuan Kelun Pharmaceutical Co., Ltd. | 国药准字H20233134150mg | — | Official source ↗ |
| Fujian Sheng Bao Nuo Pharmaceuticals Research and Development Co., Ltd. romanized | 国药准字H2024911575mg | — | Official source ↗ |
| Chongqing Pharmaceuticals (Group) Co., Ltd. romanized | 国药准字H20243305150mg | — | Official source ↗ |
| Ningbo Shuang Cheng Pharma Co., Ltd. romanized | 国药准字H2024333075mg | — | Official source ↗ |
| Hunan Dong Ting Pharma Co., Ltd. romanized | 国药准字H2023355775mg | — | Official source ↗ |
| Upjohn EESV | 国药准字J20160022150mg | — | Official source ↗ |
| Yang Zi Jiang Pharma Group Nanjing Hai Ling Pharma Co., Ltd. romanized | 国药准字H2022358875mg | — | Official source ↗ |
| De Quan Medicines (Jiangsu) Co., Ltd. romanized | 国药准字H2023325575mg | — | Official source ↗ |
| Sichuan Kelun Pharmaceutical Co., Ltd. | 国药准字H2023313375mg | — | Official source ↗ |
| Sichuan Pharmaceutical Formulations Co., Ltd. romanized | 国药准字H2023392275mg | — | Official source ↗ |
| CSPC OUYI PHARMACEUTICAL CO., LTD. | 国药准字H2021344975mg | — | Official source ↗ |
| Ya Bao Pharma Group Co., Ltd. romanized | 国药准字H2022395775mg | — | Official source ↗ |
| Ningbo Ke Er Kang Mei Nuo Hua Pharma Co., Ltd. romanized | 国药准字H2020364175mg | — | Official source ↗ |
| Zhejiang AngLiKang Pharmaceutical CO.,LTD. | 国药准字H2025318075mg | — | Official source ↗ |
| ZHE JIANG HUA HAI PHARMACEUTICALCO.,LTD. | 国药准字H2021376575mg | — | Official source ↗ |
| Guangdong Jiu Rui Technology Kai Fa Co., Ltd. romanized | 国药准字H2022371275mg | — | Official source ↗ |
| Ao Mei Pharmaceutical (Hainan) Co., Ltd. romanized | 国药准字H20243328150mg | — | Official source ↗ |
| Qi Lu Pharmaceutical (Hainan) Co., Ltd. romanized | 国药准字H2020304075mg | — | Official source ↗ |
| Dr.Reddy's Laboratories Limited | 国药准字HJ2023009775mg | — | Official source ↗ |
| Shijiazhuang Long Ze Pharmaceutical Co., Ltd. romanized | 国药准字H2021370325mg | — | Official source ↗ |
| Hunan Bao Bao Tuan Pharma Co., Ltd. romanized | 国药准字H20243261150mg | — | Official source ↗ |
| Guangdong Jin Cheng Jin Su Pharmaceutical Co., Ltd. romanized | 国药准字H2023316775mg | — | Official source ↗ |
| Hua Run Shuang He Pharma Co., Ltd. romanized | 国药准字H2020355075mg | — | Official source ↗ |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H2024321175mg | — | Official source ↗ |
| Fujian Sheng Bao Nuo Pharmaceuticals Research and Development Co., Ltd. romanized | 国药准字H2024911575mg | — | Official source ↗ |
| Chongqing Pharmaceuticals (Group) Co., Ltd. romanized | 国药准字H20243305150mg | — | Official source ↗ |
| Hunan Dong Ting Pharma Co., Ltd. romanized | 国药准字H2023355775mg | — | Official source ↗ |
| Sichuan Kelun Pharmaceutical Co., Ltd. | 国药准字H2023313375mg | — | Official source ↗ |
| Sichuan Pharmaceutical Formulations Co., Ltd. romanized | 国药准字H2023392275mg | — | Official source ↗ |
| Ningbo Ke Er Kang Mei Nuo Hua Pharma Co., Ltd. romanized | 国药准字H2020364175mg | — | Official source ↗ |
| Zhejiang AngLiKang Pharmaceutical CO.,LTD. | 国药准字H2025318075mg | — | Official source ↗ |
| ZHE JIANG HUA HAI PHARMACEUTICALCO.,LTD. | 国药准字H2021376575mg | — | Official source ↗ |
| Guangdong Jiu Rui Technology Kai Fa Co., Ltd. romanized | 国药准字H2022371275mg | — | Official source ↗ |
| Upjohn EESV | 国药准字HJ2015062075mg | — | Official source ↗ |
| Shijiazhuang Long Ze Pharmaceutical Co., Ltd. romanized | 国药准字H2021370325mg | — | Official source ↗ |
| Hunan Bao Bao Tuan Pharma Co., Ltd. romanized | 国药准字H20243261150mg | — | Official source ↗ |
| Guangdong Jin Cheng Jin Su Pharmaceutical Co., Ltd. romanized | 国药准字H2023316775mg | — | Official source ↗ |
| Hua Run Shuang He Pharma Co., Ltd. romanized | 国药准字H2020355075mg | — | Official source ↗ |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H2024321175mg | — | Official source ↗ |
| Ningbo Ke Er Kang Mei Nuo Hua Pharma Co., Ltd. romanized | 国药准字H2020364175mg | — | Official source ↗ |
| ZHE JIANG HUA HAI PHARMACEUTICALCO.,LTD. | 国药准字H2021376575mg | — | Official source ↗ |
| Shijiazhuang Long Ze Pharmaceutical Co., Ltd. romanized | 国药准字H2021370325mg | — | Official source ↗ |
| Hunan Bao Bao Tuan Pharma Co., Ltd. romanized | 国药准字H20243261150mg | — | Official source ↗ |
| Hua Run Shuang He Pharma Co., Ltd. romanized | 国药准字H2020355075mg | — | Official source ↗ |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H2024321175mg | — | Official source ↗ |
| Ningbo Ke Er Kang Mei Nuo Hua Pharma Co., Ltd. romanized | 国药准字H2020364175mg | — | Official source ↗ |
| Shijiazhuang Long Ze Pharmaceutical Co., Ltd. romanized | 国药准字H2021370325mg | — | Official source ↗ |
| Hunan Bao Bao Tuan Pharma Co., Ltd. romanized | 国药准字H20243261150mg | — | Official source ↗ |
| Hua Run Shuang He Pharma Co., Ltd. romanized | 国药准字H2020355075mg | — | Official source ↗ |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H2024321175mg | — | Official source ↗ |
| Ningbo Ke Er Kang Mei Nuo Hua Pharma Co., Ltd. romanized | 国药准字H2020364175mg | — | Official source ↗ |
| Hunan Bao Bao Tuan Pharma Co., Ltd. romanized | 国药准字H20243261150mg | — | Official source ↗ |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H2024321175mg | — | Official source ↗ |
| Hunan Bao Bao Tuan Pharma Co., Ltd. romanized | 国药准字H20243261150mg | — | Official source ↗ |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H2024321175mg | — | Official source ↗ |
| Hunan Bao Bao Tuan Pharma Co., Ltd. romanized | 国药准字H20243261150mg | — | Official source ↗ |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H2024321175mg | — | Official source ↗ |
| Hunan Bao Bao Tuan Pharma Co., Ltd. romanized | 国药准字H20243261150mg | — | Official source ↗ |
| Hunan Bao Bao Tuan Pharma Co., Ltd. romanized | 国药准字H20243261150mg | — | Official source ↗ |
| Hunan Bao Bao Tuan Pharma Co., Ltd. romanized | 国药准字H20243261150mg | — | Official source ↗ |
| Hunan Bao Bao Tuan Pharma Co., Ltd. romanized | 国药准字H20243261150mg | — | Official source ↗ |
| Hunan Bao Bao Tuan Pharma Co., Ltd. romanized | 国药准字H20243261150mg | — | Official source ↗ |
| Hunan Bao Bao Tuan Pharma Co., Ltd. romanized | 国药准字H20243261150mg | — | Official source ↗ |
| Hunan Bao Bao Tuan Pharma Co., Ltd. romanized | 国药准字H20243261150mg | — | Official source ↗ |
| Hunan Bao Bao Tuan Pharma Co., Ltd. romanized | 国药准字H20243261150mg | — | Official source ↗ |
| Chongqing Sai Wei Pharma Co., Ltd. romanized | 国药准字H2013006525mg | — | Official source ↗ |
| Hunan Dong Ting Pharma Co., Ltd. romanized | 国药准字H20233558150mg | — | Official source ↗ |
| Upjohn EESV | 国药准字J2016002175mg | — | Official source ↗ |
| Yang Zi Jiang Pharma Group Nanjing Hai Ling Pharma Co., Ltd. romanized | 国药准字H20223587150mg | — | Official source ↗ |
| Sichuan Pharmaceutical Formulations Co., Ltd. romanized | 国药准字H20233923150mg | — | Official source ↗ |
| CSPC OUYI PHARMACEUTICAL CO., LTD. | 国药准字H20213450150mg | — | Official source ↗ |
| Ya Bao Pharma Group Co., Ltd. romanized | 国药准字H20223958150mg | — | Official source ↗ |
| Shandong Dan Hong Pharmaceutical Co., Ltd. romanized | 国药准字H20234017150mg | — | Official source ↗ |
| SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED | 国药准字H2024397775mg | — | Official source ↗ |
| Ningbo Ke Er Kang Mei Nuo Hua Pharma Co., Ltd. romanized | 国药准字H20203640150mg | — | Official source ↗ |
| Zhejiang AngLiKang Pharmaceutical CO.,LTD. | 国药准字H20253179150mg | — | Official source ↗ |
| ZHE JIANG HUA HAI PHARMACEUTICALCO.,LTD. | 国药准字H20213766100mg | — | Official source ↗ |
| Guangdong Jiu Rui Technology Kai Fa Co., Ltd. romanized | 国药准字H20223713100mg | — | Official source ↗ |
| Ao Mei Pharmaceutical (Hainan) Co., Ltd. romanized | 国药准字H2024332975mg | — | Official source ↗ |
| Qi Lu Pharmaceutical (Hainan) Co., Ltd. romanized | 国药准字H20203041150mg | — | Official source ↗ |
| Dr.Reddy's Laboratories Limited | 国药准字HJ20230098150mg | — | Official source ↗ |
| Upjohn EESV | 国药准字HJ20150623150mg | — | Official source ↗ |
| Shijiazhuang Long Ze Pharmaceutical Co., Ltd. romanized | 国药准字H2021370250mg | — | Official source ↗ |
| Hunan Bao Bao Tuan Pharma Co., Ltd. romanized | 国药准字H2024728075mg | — | Official source ↗ |
| Tian Di Heng Yi Pharmaceutical Co., Ltd. romanized | 国药准字H20223306150mg | — | Official source ↗ |
| Da Tong Pharmaceutical (Zhongguo) Co., Ltd. romanized | 国药准字H20253195150mg | — | Official source ↗ |
| Guangdong Jin Cheng Jin Su Pharmaceutical Co., Ltd. romanized | 国药准字H20233166100mg | — | Official source ↗ |
| Hua Run Shuang He Pharma Co., Ltd. romanized | 国药准字H20203551150mg | — | Official source ↗ |
| Hainan Wan Wei Pharmaceutical Co., Ltd. romanized | 国药准字H20213340150mg | — | Official source ↗ |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243210100mg | — | Official source ↗ |
| Fujian Sheng Bao Nuo Pharmaceuticals Research and Development Co., Ltd. romanized | 国药准字H20249116150mg | — | Official source ↗ |
| Ningbo Shuang Cheng Pharma Co., Ltd. romanized | 国药准字H20243331300mg | — | Official source ↗ |
| Hunan Dong Ting Pharma Co., Ltd. romanized | 国药准字H20233558150mg | — | Official source ↗ |
| Upjohn EESV | 国药准字J2016002175mg | — | Official source ↗ |
| Yang Zi Jiang Pharma Group Nanjing Hai Ling Pharma Co., Ltd. romanized | 国药准字H20223587150mg | — | Official source ↗ |
| Ya Bao Pharma Group Co., Ltd. romanized | 国药准字H20223958150mg | — | Official source ↗ |
| Ningbo Ke Er Kang Mei Nuo Hua Pharma Co., Ltd. romanized | 国药准字H20203640150mg | — | Official source ↗ |
| Zhejiang AngLiKang Pharmaceutical CO.,LTD. | 国药准字H20253179150mg | — | Official source ↗ |
| ZHE JIANG HUA HAI PHARMACEUTICALCO.,LTD. | 国药准字H20213766100mg | — | Official source ↗ |
| Ao Mei Pharmaceutical (Hainan) Co., Ltd. romanized | 国药准字H2024332975mg | — | Official source ↗ |
| Qi Lu Pharmaceutical (Hainan) Co., Ltd. romanized | 国药准字H20203041150mg | — | Official source ↗ |
| Shijiazhuang Long Ze Pharmaceutical Co., Ltd. romanized | 国药准字H2021370250mg | — | Official source ↗ |
| Hunan Bao Bao Tuan Pharma Co., Ltd. romanized | 国药准字H2024728075mg | — | Official source ↗ |
| Tian Di Heng Yi Pharmaceutical Co., Ltd. romanized | 国药准字H20223306150mg | — | Official source ↗ |
| Guangdong Jin Cheng Jin Su Pharmaceutical Co., Ltd. romanized | 国药准字H20233166100mg | — | Official source ↗ |
| Hua Run Shuang He Pharma Co., Ltd. romanized | 国药准字H20203551150mg | — | Official source ↗ |
| Hainan Wan Wei Pharmaceutical Co., Ltd. romanized | 国药准字H20213340150mg | — | Official source ↗ |
| Fujian Sheng Bao Nuo Pharmaceuticals Research and Development Co., Ltd. romanized | 国药准字H20249116150mg | — | Official source ↗ |
| Hunan Dong Ting Pharma Co., Ltd. romanized | 国药准字H20233558150mg | — | Official source ↗ |
| Upjohn EESV | 国药准字J2016002175mg | — | Official source ↗ |
| Ningbo Ke Er Kang Mei Nuo Hua Pharma Co., Ltd. romanized | 国药准字H20203640150mg | — | Official source ↗ |
| Zhejiang AngLiKang Pharmaceutical CO.,LTD. | 国药准字H20253179150mg | — | Official source ↗ |
| ZHE JIANG HUA HAI PHARMACEUTICALCO.,LTD. | 国药准字H20213766100mg | — | Official source ↗ |
| Shijiazhuang Long Ze Pharmaceutical Co., Ltd. romanized | 国药准字H2021370250mg | — | Official source ↗ |
| Hunan Bao Bao Tuan Pharma Co., Ltd. romanized | 国药准字H2024728075mg | — | Official source ↗ |
| Tian Di Heng Yi Pharmaceutical Co., Ltd. romanized | 国药准字H20223306150mg | — | Official source ↗ |
| Hua Run Shuang He Pharma Co., Ltd. romanized | 国药准字H20203551150mg | — | Official source ↗ |
| Hainan Wan Wei Pharmaceutical Co., Ltd. romanized | 国药准字H20213340150mg | — | Official source ↗ |
| Fujian Sheng Bao Nuo Pharmaceuticals Research and Development Co., Ltd. romanized | 国药准字H20249116150mg | — | Official source ↗ |
| Ningbo Ke Er Kang Mei Nuo Hua Pharma Co., Ltd. romanized | 国药准字H20203640150mg | — | Official source ↗ |
| ZHE JIANG HUA HAI PHARMACEUTICALCO.,LTD. | 国药准字H20213766100mg | — | Official source ↗ |
| Shijiazhuang Long Ze Pharmaceutical Co., Ltd. romanized | 国药准字H2021370250mg | — | Official source ↗ |
| Hunan Bao Bao Tuan Pharma Co., Ltd. romanized | 国药准字H2024728075mg | — | Official source ↗ |
| Hainan Wan Wei Pharmaceutical Co., Ltd. romanized | 国药准字H20213340150mg | — | Official source ↗ |
| Ningbo Ke Er Kang Mei Nuo Hua Pharma Co., Ltd. romanized | 国药准字H20203640150mg | — | Official source ↗ |
| Shijiazhuang Long Ze Pharmaceutical Co., Ltd. romanized | 国药准字H2021370250mg | — | Official source ↗ |
| Hunan Bao Bao Tuan Pharma Co., Ltd. romanized | 国药准字H2024728075mg | — | Official source ↗ |
| Hainan Wan Wei Pharmaceutical Co., Ltd. romanized | 国药准字H20213340150mg | — | Official source ↗ |
| Ningbo Ke Er Kang Mei Nuo Hua Pharma Co., Ltd. romanized | 国药准字H20203640150mg | — | Official source ↗ |
| Hunan Bao Bao Tuan Pharma Co., Ltd. romanized | 国药准字H2024728075mg | — | Official source ↗ |
| Hunan Bao Bao Tuan Pharma Co., Ltd. romanized | 国药准字H2024728075mg | — | Official source ↗ |
| Hunan Bao Bao Tuan Pharma Co., Ltd. romanized | 国药准字H2024728075mg | — | Official source ↗ |
| Hunan Bao Bao Tuan Pharma Co., Ltd. romanized | 国药准字H2024728075mg | — | Official source ↗ |
| Hunan Bao Bao Tuan Pharma Co., Ltd. romanized | 国药准字H2024728075mg | — | Official source ↗ |
| Hunan Bao Bao Tuan Pharma Co., Ltd. romanized | 国药准字H2024728075mg | — | Official source ↗ |
| Hunan Bao Bao Tuan Pharma Co., Ltd. romanized | 国药准字H2024728075mg | — | Official source ↗ |
| Hunan Bao Bao Tuan Pharma Co., Ltd. romanized | 国药准字H2024728075mg | — | Official source ↗ |
| Hunan Bao Bao Tuan Pharma Co., Ltd. romanized | 国药准字H2024728075mg | — | Official source ↗ |
| Hunan Bao Bao Tuan Pharma Co., Ltd. romanized | 国药准字H2024728075mg | — | Official source ↗ |
| Hunan Bao Bao Tuan Pharma Co., Ltd. romanized | 国药准字H2024728075mg | — | Official source ↗ |
| Chongqing Sai Wei Pharma Co., Ltd. romanized | 国药准字H2013007375mg | — | Official source ↗ |
| Upjohn EESV | 国药准字J20160022150mg | — | Official source ↗ |
| ZHE JIANG HUA HAI PHARMACEUTICALCO.,LTD. | 国药准字H20213767150mg | — | Official source ↗ |
| Shijiazhuang Long Ze Pharmaceutical Co., Ltd. romanized | 国药准字H2021370475mg | — | Official source ↗ |
| Tian Di Heng Yi Pharmaceutical Co., Ltd. romanized | 国药准字H20223307300mg | — | Official source ↗ |
| Hainan Wan Wei Pharmaceutical Co., Ltd. romanized | 国药准字H2021333975mg | — | Official source ↗ |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20234482150mg | — | Official source ↗ |
| Chongqing Sai Wei Pharma Co., Ltd. romanized | 国药准字H2013007375mg | — | Official source ↗ |
| ZHE JIANG HUA HAI PHARMACEUTICALCO.,LTD. | 国药准字H20213767150mg | — | Official source ↗ |
| Shijiazhuang Long Ze Pharmaceutical Co., Ltd. romanized | 国药准字H2021370475mg | — | Official source ↗ |
| Hainan Wan Wei Pharmaceutical Co., Ltd. romanized | 国药准字H2021333975mg | — | Official source ↗ |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20234482150mg | — | Official source ↗ |
| ZHE JIANG HUA HAI PHARMACEUTICALCO.,LTD. | 国药准字H20213767150mg | — | Official source ↗ |
| Shijiazhuang Long Ze Pharmaceutical Co., Ltd. romanized | 国药准字H2021370475mg | — | Official source ↗ |
| Hainan Wan Wei Pharmaceutical Co., Ltd. romanized | 国药准字H2021333975mg | — | Official source ↗ |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20234482150mg | — | Official source ↗ |
| Shijiazhuang Long Ze Pharmaceutical Co., Ltd. romanized | 国药准字H2021370475mg | — | Official source ↗ |
| Hainan Wan Wei Pharmaceutical Co., Ltd. romanized | 国药准字H2021333975mg | — | Official source ↗ |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20234482150mg | — | Official source ↗ |
| Shijiazhuang Long Ze Pharmaceutical Co., Ltd. romanized | 国药准字H2021370475mg | — | Official source ↗ |
| Hainan Wan Wei Pharmaceutical Co., Ltd. romanized | 国药准字H2021333975mg | — | Official source ↗ |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20234482150mg | — | Official source ↗ |
| Shijiazhuang Long Ze Pharmaceutical Co., Ltd. romanized | 国药准字H2021370475mg | — | Official source ↗ |
| Hainan Wan Wei Pharmaceutical Co., Ltd. romanized | 国药准字H2021333975mg | — | Official source ↗ |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20234482150mg | — | Official source ↗ |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20234482150mg | — | Official source ↗ |
| Shijiazhuang Long Ze Pharmaceutical Co., Ltd. romanized | 国药准字H2021370475mg | — | Official source ↗ |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20234482150mg | — | Official source ↗ |
| Shijiazhuang Long Ze Pharmaceutical Co., Ltd. romanized | 国药准字H2021370475mg | — | Official source ↗ |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20234482150mg | — | Official source ↗ |
| Shijiazhuang Long Ze Pharmaceutical Co., Ltd. romanized | 国药准字H2021370475mg | — | Official source ↗ |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20234482150mg | — | Official source ↗ |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20234482150mg | — | Official source ↗ |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20234482150mg | — | Official source ↗ |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20234482150mg | — | Official source ↗ |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20234482150mg | — | Official source ↗ |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20234482150mg | — | Official source ↗ |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20234482150mg | — | Official source ↗ |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20234482150mg | — | Official source ↗ |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20234482150mg | — | Official source ↗ |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20234482150mg | — | Official source ↗ |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20234482150mg | — | Official source ↗ |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20234482150mg | — | Official source ↗ |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20234482150mg | — | Official source ↗ |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20234482150mg | — | Official source ↗ |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20234482150mg | — | Official source ↗ |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20234482150mg | — | Official source ↗ |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20234482150mg | — | Official source ↗ |
| Chongqing Sai Wei Pharma Co., Ltd. romanized | 国药准字H2013007375mg | — | Official source ↗ |
| Shijiazhuang Long Ze Pharmaceutical Co., Ltd. romanized | 国药准字H20213705100mg | — | Official source ↗ |
| Shijiazhuang Long Ze Pharmaceutical Co., Ltd. romanized | 国药准字H20213705100mg | — | Official source ↗ |
| Chongqing Sai Wei Pharma Co., Ltd. romanized | 国药准字H2013007375mg | — | Official source ↗ |
| Shijiazhuang Long Ze Pharmaceutical Co., Ltd. romanized | 国药准字H20213705100mg | — | Official source ↗ |
| Chongqing Sai Wei Pharma Co., Ltd. romanized | 国药准字H2013007375mg | — | Official source ↗ |
| Shijiazhuang Long Ze Pharmaceutical Co., Ltd. romanized | 国药准字H20213705100mg | — | Official source ↗ |
| Shijiazhuang Long Ze Pharmaceutical Co., Ltd. romanized | 国药准字H20213705100mg | — | Official source ↗ |
| Shijiazhuang Long Ze Pharmaceutical Co., Ltd. romanized | 国药准字H20213706150mg | — | Official source ↗ |
| Shijiazhuang Long Ze Pharmaceutical Co., Ltd. romanized | 国药准字H20213706150mg | — | Official source ↗ |
| Shijiazhuang Long Ze Pharmaceutical Co., Ltd. romanized | 国药准字H20213706150mg | — | Official source ↗ |
| Shijiazhuang Long Ze Pharmaceutical Co., Ltd. romanized | 国药准字H20213706150mg | — | Official source ↗ |
| Shijiazhuang Long Ze Pharmaceutical Co., Ltd. romanized | 国药准字H20213706150mg | — | Official source ↗ |
Under review 12
| Company (original) | Identifier (original) | Source date | Official source |
|---|---|---|---|
| Yan Tai Lu Yin Pharma Co., Ltd. romanized | CYHS2504260 | 2025/12/11 | Official source ↗ |
| Yan Tai Lu Yin Pharma Co., Ltd. romanized | CYHS2504259 | 2025/12/11 | Official source ↗ |
| Yan Tai Lu Yin Pharma Co., Ltd. romanized | CYHS2504258 | 2025/12/11 | Official source ↗ |
| Sichuan Pharmaceutical Formulations Co., Ltd. romanized | CYHB2600369 | 2026/02/24 | Official source ↗ |
| Chengdu Heng Rui Pharmaceutical Co., Ltd. romanized | CYHS2600422 | 2026/02/10 | Official source ↗ |
| Zhejiang Apeloa Kangyu Pharmaceutical Co., Ltd. | CYHS2504522 | 2026/01/01 | Official source ↗ |
| Zhejiang Apeloa Kangyu Pharmaceutical Co., Ltd. | CYHS2504521 | 2026/01/01 | Official source ↗ |
| Zhejiang Apeloa Kangyu Pharmaceutical Co., Ltd. | CYHS2504520 | 2026/01/01 | Official source ↗ |
| CISEN PHARMACEUTICAL CO., LTD. | CYHS2503818 | 2025/10/29 | Official source ↗ |
| CISEN PHARMACEUTICAL CO., LTD. | CYHS2503817 | 2025/10/29 | Official source ↗ |
| Shijiazhuang Shi Hua Xin Pharma Co., Ltd. romanized | CYHS2502144 | 2025/06/17 | Official source ↗ |
| Shijiazhuang Shi Hua Xin Pharma Co., Ltd. romanized | CYHS2502143 | 2025/06/17 | Official source ↗ |
Generic-filing companies this year 2
| Company (original) | Identifier (original) | Source date | Official source |
|---|---|---|---|
| Chengdu Heng Rui Pharmaceutical Co., Ltd. romanized | CYHS2600422 | 2026/02/10 | Official source ↗ |
| Zhejiang Apeloa Kangyu Pharmaceutical Co., Ltd. | CYHS2504522 | 2026/01/01 | Official source ↗ |
| Zhejiang Apeloa Kangyu Pharmaceutical Co., Ltd. | CYHS2504521 | 2026/01/01 | Official source ↗ |
| Zhejiang Apeloa Kangyu Pharmaceutical Co., Ltd. | CYHS2504520 | 2026/01/01 | Official source ↗ |
API companies with A status 25
| Company (original) | Identifier (original) | Source date | Official source |
|---|---|---|---|
| MSN Pharmachem Private Limited | Y20240000210 | 2026/05/20 | Official source ↗ |
| Upjohn EESV | Y20230001164 | 2025/12/29 | Official source ↗ |
| Shuang He Pharma (Shang Qiu) Co., Ltd. romanized | Y20230000632 | 2025/04/07 | Official source ↗ |
| Hikal Limited | Y20220000761 | 2025/04/22 | Official source ↗ |
| Hunan Sai Long Pharma Co., Ltd. romanized | Y20210000955 | 2024/03/07 | Official source ↗ |
| Dong Bei Pharmaceutical Group Co., Ltd. romanized | Y20210000638 | 2024/01/24 | Official source ↗ |
| MSN Life Sciences Private Limited Unit - III romanized | Y20200001043 | 2025/08/16 | Official source ↗ |
| Divi’s Laboratories Limited | Y20210000256 | 2024/01/17 | Official source ↗ |
| DR. REDDYS LABORATORIES LIMITED | Y20200000823 | 2026/07/11 | Official source ↗ |
| Jiangsu Hui Ju Pharma Co., Ltd. romanized | Y20190000654 | 2026/04/24 | Official source ↗ |
| CSPC OUYI PHARMACEUTICAL CO., LTD. | Y20190021404 | 2026/03/17 | Official source ↗ |
| Shijiazhuang Long Ze Pharmaceutical Co., Ltd. romanized | Y20190021315 | 2026/04/20 | Official source ↗ |
| Chongqing Sai Wei Pharma Co., Ltd. romanized | Y20190009848 | — | Official source ↗ |
| Chongqing Sai Wei Pharma Co., Ltd. romanized | Y20190000198 | 2025/09/25 | Official source ↗ |
| Ao Rui Te Pharma Co., Ltd. romanized | Y20190000368 | 2026/08/14 | Official source ↗ |
| Zhejiang Tian Yu Pharma Co., Ltd. romanized | Y20180001381 | 2026/01/13 | Official source ↗ |
| Zhejiang Mei Nuo Hua Drug Chemical Co., Ltd. romanized | Y20180001513 | 2025/07/18 | Official source ↗ |
| Jiangsu En Hua Pharma Co., Ltd. romanized | Y20170001560 | 2023/07/14 | Official source ↗ |
| Shuang He Pharma (Shang Qiu) Co., Ltd. romanized | Y20170001559 | 2023/05/11 | Official source ↗ |
| ZHE JIANG HUA HAI PHARMACEUTICALCO.,LTD. | Y20170001497 | 2023/08/16 | Official source ↗ |
| Guo Yao Group Yi Bin Pharmaceutical Co., Ltd. romanized | Y20170001200 | 2024/04/26 | Official source ↗ |
| Hetero Drugs Limited, Unit- IX | Y20170001183 | 2025/12/06 | Official source ↗ |
| Lang Fang Gao Bo Jing Bang Pharmaceutical Co., Ltd. romanized | Y20170001167 | 2022/09/08 | Official source ↗ |
| SUN PHARMACEUTICAL INDUSTRIES LTD | Y20170000832 | 2022/09/05 | Official source ↗ |
| Shandong An Hong Pharmaceutical Co., Ltd. romanized | Y20170000821 | 2026/10/30 | Official source ↗ |
| Alembic Pharmaceuticals Ltd. | Y20170000779 | 2026/03/19 | Official source ↗ |
| CTX Lifesciences Pvt. Ltd. | Y20170000558 | 2026/08/22 | Official source ↗ |
Trial registrations 2025/2026 —
Not loaded
Sources and dates
- FDA Orange Book
- 2026/11/06
- CDE acceptance and review
- 2026/11/13 06:42
- Chemical Drug Catalog
- 2026/11/13 06:39
- API registration records
- 2026/11/13 06:41
- NHSA drug code database
- 2026/10/23
- Trial registry
- 2026/11/13 08:09 · Incomplete coverage
Chinese counts use complete ingredient, dosage-form and route matches. Unmatched and partial rows show name-source matching only and make no finding about Chinese approvals or filings. Trials cover registration-number years 2025/2026 only.
Comparison generated: 2026/11/13 18:41 · openFDA Orange Book ↗
Name and dosage-form matching sources
- NMPA reference-product directory, Shaanxi MPA republication ↗ · 30-118 · 2022/09/13
Subscriptions
Next-day facts and deliverable timelines
- One email the next day when new facts are collected for your followed products.
- Export the complete loaded event timeline for each followed product as CSV.
- Add up to 4 additional recipients, each confirmed by email.
- Increase your follow limit from 3 to 10 products.
Quarterly
US$540
Billed every three months
US$180 per month
Sign in to subscribeYearly
US$1,920
Billed every year
US$160 per month
Sign in to subscribeNeed more than 10 followed products or more than 5 recipients? Contact us.
Separate one-time purchase
US Orange Book × China records comparison
Full table and CSV export for 12 months from payment, with monthly data updates. No automatic renewal.
Subscriptions and comparison-table access are purchased separately. Neither includes the other.
Billed by Creem, our merchant of record · Terms · Refund policy